Twist Bioscience Community
NasdaqGS:TWST Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 19 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 11 Analysts
Cutting-edge DNA Synthesis Platform And Cost Reductions Will Power Future Market Expansion
Key Takeaways Twist Bioscience's innovative DNA synthesis platform and strategic process improvements aim to drive revenue growth and enhance net margins. Focus on achieving EBITDA breakeven and maintaining revenue growth without additional capital points to a strong path to cash flow positivity.
View narrativeUS$54.38
FV
31.0% undervalued intrinsic discount18.75%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
1 day ago author updated this narrative